Claro Advisors LLC grew its stake in The Sherwin-Williams Company (NYSE:SHW – Free Report) by 5.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,105 shares of the specialty chemicals company’s stock after purchasing an additional 149 shares during the period. Claro Advisors LLC’s holdings in Sherwin-Williams were worth $1,185,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Valued Wealth Advisors LLC boosted its position in shares of Sherwin-Williams by 88.9% during the 3rd quarter. Valued Wealth Advisors LLC now owns 68 shares of the specialty chemicals company’s stock valued at $26,000 after acquiring an additional 32 shares in the last quarter. HHM Wealth Advisors LLC boosted its position in shares of Sherwin-Williams by 102.3% during the 2nd quarter. HHM Wealth Advisors LLC now owns 89 shares of the specialty chemicals company’s stock valued at $27,000 after acquiring an additional 45 shares in the last quarter. First Personal Financial Services acquired a new stake in shares of Sherwin-Williams during the 3rd quarter valued at about $29,000. Semmax Financial Advisors Inc. boosted its position in shares of Sherwin-Williams by 136.4% during the 2nd quarter. Semmax Financial Advisors Inc. now owns 104 shares of the specialty chemicals company’s stock valued at $31,000 after acquiring an additional 60 shares in the last quarter. Finally, VitalStone Financial LLC boosted its position in shares of Sherwin-Williams by 233.3% during the 2nd quarter. VitalStone Financial LLC now owns 110 shares of the specialty chemicals company’s stock valued at $33,000 after acquiring an additional 77 shares in the last quarter. 77.67% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several analysts have recently weighed in on the stock. JPMorgan Chase & Co. lifted their target price on shares of Sherwin-Williams from $360.00 to $370.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Royal Bank of Canada decreased their target price on shares of Sherwin-Williams from $455.00 to $446.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Evercore ISI lifted their price target on shares of Sherwin-Williams from $400.00 to $420.00 and gave the company an “outperform” rating in a report on Thursday, November 7th. Wells Fargo & Company lifted their price target on shares of Sherwin-Williams from $350.00 to $400.00 and gave the company an “equal weight” rating in a report on Tuesday, October 15th. Finally, Barclays lifted their price target on shares of Sherwin-Williams from $355.00 to $370.00 and gave the company an “equal weight” rating in a report on Wednesday, October 23rd. One analyst has rated the stock with a sell rating, seven have given a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $396.47.
Sherwin-Williams Stock Down 2.4 %
Shares of NYSE:SHW opened at $378.99 on Monday. The Sherwin-Williams Company has a one year low of $264.54 and a one year high of $392.57. The company has a 50 day moving average of $376.42 and a 200-day moving average of $342.26. The company has a debt-to-equity ratio of 1.97, a current ratio of 0.83 and a quick ratio of 0.51. The stock has a market cap of $95.45 billion, a price-to-earnings ratio of 37.75, a P/E/G ratio of 3.05 and a beta of 1.17.
Sherwin-Williams (NYSE:SHW – Get Free Report) last issued its quarterly earnings results on Tuesday, October 22nd. The specialty chemicals company reported $3.37 EPS for the quarter, missing the consensus estimate of $3.56 by ($0.19). Sherwin-Williams had a return on equity of 74.45% and a net margin of 11.09%. The business had revenue of $6.16 billion for the quarter, compared to analyst estimates of $6.20 billion. During the same quarter in the prior year, the firm earned $3.20 EPS. The firm’s quarterly revenue was up .7% compared to the same quarter last year. On average, sell-side analysts forecast that The Sherwin-Williams Company will post 11.32 earnings per share for the current year.
Sherwin-Williams Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be given a dividend of $0.715 per share. This represents a $2.86 annualized dividend and a dividend yield of 0.75%. The ex-dividend date is Friday, November 15th. Sherwin-Williams’s dividend payout ratio is 28.49%.
Insider Transactions at Sherwin-Williams
In related news, CFO Allen J. Mistysyn sold 14,520 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $366.83, for a total transaction of $5,326,371.60. Following the completion of the transaction, the chief financial officer now owns 63,520 shares in the company, valued at approximately $23,301,041.60. The trade was a 18.61 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.60% of the stock is owned by corporate insiders.
About Sherwin-Williams
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Read More
- Five stocks we like better than Sherwin-Williams
- Airline Stocks – Top Airline Stocks to Buy Now
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How to Invest in Blue Chip Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding SHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Sherwin-Williams Company (NYSE:SHW – Free Report).
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.